Diagnosis and treatment of malignant melanoma of the foot

Foot and Ankle International

Volumn 27, Issue 9, 2006, Pages 696-705

  Gray, Richard J ^a,b   Pockaj, Barbara A ^b   Vega, Miriam L ^a,b   Connolly, Suzanne M ^a,b   Dicaudo, David J ^a,b   Kile, Todd A ^a,b   Buchel, Edward W ^a,b  

^a Mayo Clinic ^*

^b MAYO CLINIC   (United States)

Author keywords

Complication; Foot; Mapping; Melanoma; Sentinel Lymph

Indexed keywords

ADULT; AGED; AMERICAN INDIAN; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CAUCASIAN; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOOT; HISTOPATHOLOGY; HUMAN; MALE; MELANOMA; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SKIN TRANSPLANTATION; STATISTICAL ANALYSIS; SURVIVAL RATE; TISSUE FLAP;

EID: 33748553042     PISSN: 10711007     EISSN: None     Source Type: Journal    
DOI: 10.1177/107110070602700908     Document Type: Article

References (44)

1. Ahmed, I: Malignant melanoma: prognostic indicators. Mayo Clin. Proc. 72:356-361, 1997.
2. Attinger, CE; Bulan, EJ: Debridement: The key initial first step in wound healing. Foot Ankle Clin. 6:627-660, 2001.
3. Balch, CM; Buzaid, AC; Soong, SJ; et al.: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J. Clin. Oncol. 19:3635-3648, 2001.
4. Balch, CM; Soong, S-J; Gershenwald, JE; et al.: Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer Melanoma Staging System. J. Clin. Oncol. 19:3622-3634, 2001.
5. Balch, CM; Soong, SJ; Smith, T; et al.: Investigators from the Intergroup Melanoma Surgical Trial: Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann. Surg. Oncol. 8:101-108, 2001.
6. Barnes, BC; Seigler, HF; Saxby, TS; Kocher, MS; Harrelson, JM: Melanoma of the foot. J. Bone Joint Surg. 76-A:892-898, 1994.
7. Barnhill, RL: Tumors of melanocytes. In: Barnhill, RL; Crowson, AN; Busam, KJ; Granter, SR, eds, Textbook of Dermatopathology, McGraw-Hill, New York, pp. 537-591, 1998.
8. Bennett, DR; Wasson, D; MacArthur, JD; McMillen, MA: The effect of misdiagnosis and delay in diagnosis on clinical outcome in melanomas of the foot. J. Am. Coll. Surg. 179:279-284, 1994.
9. Breslow, A: Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg. 172:902-908, 1970.
10. Clark, WH, Jr; Elder, DE; Van Horn, M: The biologic forms of malignant melanoma. Hum. Pathol. 17:443-450, 1986.
11. Clark, WH Jr; From, L; Bernardino, EA; Mihm, MC: The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 29:705-727, 1969.
12. Day, CL, Jr; Sober, AJ; Kopf, AW, et al.: A prognostic model for clinical stage I melanoma of the lower extremity: location on foot as independent risk factor for recurrent disease. Surgery 89:599-603, 1981.
13. Dwyer, PK; Mackie, RM; Watt, DC; Aitchison, TC: Plantar malignant melanoma in a white Caucasian population. Br. J. Dermatol. 128:115-120, 1993.
14. Fortin, PT; Freiberg, AA; Rees, R; Sondak, VK; Johnson, TM: Malignant melanoma of the foot and ankle. J. Bone Joint Surg. 77-A:1396-1403, 1995.
15. Franke, W; Neumann, NJ; Ruzicka, T; Schulte, KW: Plantar malignant melanoma: a challenge for early recognition. Melanoma Res. 10:571-576, 2000.
16. Green, A; McCredie, M; MacKie, R; et al.: A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Causes Control 10:21-25, 1999.
17. Hemo, Y; Gutman, M; Klausner, JM: Anatomic site of primary melanoma is associated with depth of invasion. Arch. Surg. 134:148-150, 1999.
18. Hsueh, EC; Lucci, A; Qi, K; Morton, DL: Survival of patients with melanoma of the lower extremity decreases with distance from the trunk. Cancer 85:383-388, 1999.
19. Hudson, DA; Fenn, C; Krige, JE; Johnson, C: Melanoma of the foot in white South Africans. Scand. J. Plast. Reconstr. Hand Surg. 30:315-319, 1996.
20. Hudson, DA; Krige, JE; Stubbings, H: Plantar melanoma: results of treatment in three population groups. Surgery 124:877-882, 1998.
21. John, KJ; Hayes, DW, Jr; Green, DR; Dickerson, J: Malignant melanoma of the foot and ankle. Clin. Podiatr. Med. Surg. 17:347-360, 2000.
22. Kato, T; Suetake, T; Tabata, N; Takahashi, K; Tagami, H: Epidemiology and prognosis of plantar melanoma in 62 Japanese patients over a 28-year period. Int. J. Dermatol. 38:515-519, 1999.
23. Katz, RD; Potter, GK; Slutskiy, PZ; et al.: A statistical survey of melanomas of the foot. J. Am. Acad. Dermatol. 28:1008-1011, 1993.
24. Kuchelmeister, C; Schaumburg-Lever, G; Garbe, C: Acral cutaneous melanoma in Caucasians: clinical features, histopathology and prognosis in 112 patients. Br. J. Dermatol. 143:275-280, 2000.
25. Kukita, A; Ishihara, K: Clinical features and distribution of malignant melanoma and pigmented nevi on the soles of the feet in Japan. J. Invest. Dermatol. 92:210S-213S, 1989.
26. Miyamoto, Y; Ikuta, Y; Shigeki, S; Yamura, M: Current concepts of instep island flap. Ann. Plast. Surg. 19:97-102, 1987.
27. Morton, DL; Wen, DR; Wong, JH; et al.: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127:392-399, 1992.
28. Oberlin, C; Azoulay, B; Bhatia, A: The posterolateral malleolar flap of the ankle: a distally based sural neurocutaneous flap: report of 14 cases. Plast. Reconstr. Surg. 96:400-405, 1995.
29. Porras, BH; Cockerell, CJ: Cutaneous malignant melanoma: classification and clinical diagnosis. Semin. Cutan. Med. Surg. 16:88-96, 1997.
30. Reed, RJ; Martin, P: Variants of melanoma. Semin. Cutan. Med. Surg. 16:137-158, 1997.
31. Reintgen, D; Pendas, S; Jakub, J; et al.: National trials involving lymphatic mapping for melanoma: the multicenter selective lymphadenectomy trial, the sunbelt melanoma trial, and the Florida melanoma trial. Semin. Oncol. 31:363-373, 2004.
32. Reintgen, DS; McCarty, KM, Jr; Cox, E; Seigler, HF: Malignant melanoma in black American and white American populations: a comparative review. J. Am. Med. Assoc. 248:1856-1859, 1982.
33. Scrivner, D; Oxenhandler, RW; Lopez, M; Perez-Mesa, C: Plantar lentiginous melanoma: a clinicopathologic study. Cancer 60:2502-2509, 1987.
34. Shaw, WW; Hidalgo, DA: Anatomic basis of plantar flap design: clinical applications. Plast. Reconstr. Surg. 78:637-649, 1986.
35. Soon, SL; Solomon, AR, Jr; Papadopoulos, D; et al.: Acral lentiginous melanoma mimicking benign disease: the Emory experience. J. Am. Acad. Dermatol. 48:183-188, 2003.
36. Soong SJ, Shaw HM, Balch CM, et al.: Predicting survival and recurrence in localized melanoma: a multivariate approach. World J. Surg. 16:191-195, 1992.
37. Stalkup, JR; Orengo, IF; Katta, R: Controversies in acral lentiginous melanoma. Dermatol. Surg. 28:1051-1059, 2002.
38. Stevens, NG; Liff, JM; Weiss, NS: Plantar melanoma: is the incidence of melanoma of the sole of the foot really higher in blacks than whites? Int. J. Cancer 45:691-693, 1990.
39. Su WP: Malignant melanoma: basic approach to clinicopathologic correlation. Mayo Clin. Proc. 72:267-272, 1997.
40. Sutherland, CM; Mather, FJ; Muchmore, JH; et al.: Acral lentiginous melanoma. Am. J. Surg. 166:64-67, 1993.
41. Talley, LI; Soong, S; Harrison, RA; et al.: Clinical outcomes of localized melanoma of the foot: a case-control study. J. Clin. Epidemiol. 51:853-857, 1998.
42. Veronesi, U; Cascinelli, N; Adamus, J; et al.: Thin stage I primary cutaneous malignant melanoma: comparison of excision with margins of 1 or 3 cm. N. Engl. J. Med. 318:1159-1162, 1988.
43. Erratum in: N. Engl. J. Med. 325:292, 1991.
44. Weltering, EA; Thorpe, WP; Reed, JK, Jr; Rosenberg, SA: Split thickness skin grafting of the plantar surface of the foot after wide excision of neoplasms of the skin. Surg. Gynecol. Obstet. 149:229-232, 1979.